Option Care Health Reports Mixed Q1 Results, Lowers Full-Year Revenue Guidance Amid Growth Challenges

summarizeSummary

Option Care Health reported mixed Q1 2026 results with slow revenue growth and declining Adjusted EBITDA, leading to a lowered full-year revenue and cash flow guidance, though profit guidance was maintained.

check_boxKey Events

• Mixed Q1 2026 Financial Performance

  Net revenue increased by a modest 1.3% to $1.35 billion, while GAAP net income decreased 3.0% and Adjusted EBITDA fell 6.3% to $104.8 million. Adjusted diluted EPS remained flat at $0.40.

• Full-Year 2026 Revenue Guidance Lowered

  The company updated its full-year 2026 net revenue guidance to a range of $5.675 billion to $5.775 billion and adjusted its cash flow from operations target to at least $320 million, reflecting slower growth momentum.

• Profit Guidance Maintained

  Despite the lowered revenue outlook, Option Care Health maintained its full-year Adjusted EBITDA guidance of $480 million to $505 million and Adjusted diluted EPS guidance of $1.82 to $1.92.

• Revolving Credit Facility Expanded

  The company expanded its revolving credit facility from $400 million to $850 million, enhancing its financial flexibility and liquidity.

auto_awesomeAnalysis

Option Care Health reported mixed first-quarter 2026 financial results, with net revenue growing only 1.3% and Adjusted EBITDA declining by 6.3%. Management explicitly stated dissatisfaction with revenue growth momentum and announced decisive actions to re-accelerate growth. The company lowered its full-year net revenue guidance and adjusted its cash flow from operations target, signaling ongoing operational challenges. While Adjusted EBITDA and Adjusted diluted EPS guidance were maintained, likely due to cost management, the reduced revenue outlook is a significant concern for investors, especially with the stock trading near its 52-week low. The expansion of the revolving credit facility provides enhanced liquidity but does not offset the underlying growth issues.